THYROID CARCINOMA, ANAPLASTIC

Clinical trials for THYROID CARCINOMA, ANAPLASTIC explained in plain language.

Never miss a new study

Get alerted when new THYROID CARCINOMA, ANAPLASTIC trials appear

Sign up with your email to follow new studies for THYROID CARCINOMA, ANAPLASTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

UK trial repurposes melanoma drugs to fight rare cancers

Disease control Recruiting now

This trial is testing if a combination of two drugs, already approved for a type of skin cancer, can help control other rare cancers that share the same genetic change (a BRAF V600 mutation). It aims to enroll 30 adult patients with various rare or uncommon cancers to see if the …

Matched conditions: THYROID CARCINOMA, ANAPLASTIC

Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

THYROID CARCINOMA, ANAPLASTIC

Get alerted when new THYROID CARCINOMA, ANAPLASTIC trials appear

UK trial repurposes melanoma drugs to fight rare cancers